Improving Decision Making during Method Development Using Empower 3 CDS Software
Technical notes | 2014 | WatersInstrumentation
The development of robust chromatographic methods is essential for achieving reliable and reproducible compound separations in pharmaceutical, environmental, and industrial laboratories.
Implementing objective, metric-driven evaluations during method development minimizes operator bias and accelerates decision making.
This study demonstrates how Empower 3 Chromatography Data Software can be used to score chromatographic separations automatically.
The goals include defining performance criteria, systematically screening chromatographic conditions, and ranking method options based on custom calculations.
A systematic screening protocol was applied, consisting of three phases: rapid scouting, screening, and optimization.
Key parameters varied included column chemistry (CSH C18, CORTECS C18+, CSH Phenyl Hexyl, HSS PFP), organic modifiers (acetonitrile, methanol), pH, gradient slope, and temperature.
The ACQUITY UPLC H-Class System equipped with PDA and QDa detectors was used to acquire chromatograms.
Custom calculations in Empower 3 were configured to compute:
Custom reports then tabulated and ranked each condition based on these metrics.
Using metoclopramide and its USP-defined related substances as a model, the protocol identified optimal column and solvent combinations without manual interpretation of chromatograms.
Empower 3 scoring removed analyst variability and highlighted the best separation conditions according to predefined criteria.
The automated ranking accelerated method selection and ensured a comprehensive assessment of all tested variables.
Automated scoring within Empower 3 streamlines method development workflows and reduces time spent on data review.
Metric-based selection improves consistency across operators and laboratories, supporting quality assurance and regulatory compliance.
This approach can be integrated into routine QC and R&D environments to enhance throughput and reliability.
Integration of machine learning algorithms with chromatographic scoring could further refine method optimization and predict performance outcomes.
Expanding custom calculation frameworks to include mass spectrometric and spectroscopic data will broaden applicability.
Cloud-based reporting and collaborative platforms may enable remote optimization and real-time decision support.
Empower 3 CDS custom calculations and reporting provide an objective, efficient, and reproducible approach to chromatographic method development.
Automated scoring minimizes bias, accelerates decision making, and ensures optimal separation conditions are selected based on quantitative metrics.
Software
IndustriesManufacturerWaters
Summary
Importance of the Topic
The development of robust chromatographic methods is essential for achieving reliable and reproducible compound separations in pharmaceutical, environmental, and industrial laboratories.
Implementing objective, metric-driven evaluations during method development minimizes operator bias and accelerates decision making.
Objectives and Study Overview
This study demonstrates how Empower 3 Chromatography Data Software can be used to score chromatographic separations automatically.
The goals include defining performance criteria, systematically screening chromatographic conditions, and ranking method options based on custom calculations.
Methodology and Instrumentation
A systematic screening protocol was applied, consisting of three phases: rapid scouting, screening, and optimization.
Key parameters varied included column chemistry (CSH C18, CORTECS C18+, CSH Phenyl Hexyl, HSS PFP), organic modifiers (acetonitrile, methanol), pH, gradient slope, and temperature.
The ACQUITY UPLC H-Class System equipped with PDA and QDa detectors was used to acquire chromatograms.
Custom calculations in Empower 3 were configured to compute:
- The total number of peaks
- Peaks with USP resolution ≥ 2.0
- Peaks with tailing ≤ 1.5
- Retention factor (k*)
- Retention time of the last eluting peak
Custom reports then tabulated and ranked each condition based on these metrics.
Key Results and Discussion
Using metoclopramide and its USP-defined related substances as a model, the protocol identified optimal column and solvent combinations without manual interpretation of chromatograms.
Empower 3 scoring removed analyst variability and highlighted the best separation conditions according to predefined criteria.
The automated ranking accelerated method selection and ensured a comprehensive assessment of all tested variables.
Benefits and Practical Applications
Automated scoring within Empower 3 streamlines method development workflows and reduces time spent on data review.
Metric-based selection improves consistency across operators and laboratories, supporting quality assurance and regulatory compliance.
This approach can be integrated into routine QC and R&D environments to enhance throughput and reliability.
Future Trends and Potential Applications
Integration of machine learning algorithms with chromatographic scoring could further refine method optimization and predict performance outcomes.
Expanding custom calculation frameworks to include mass spectrometric and spectroscopic data will broaden applicability.
Cloud-based reporting and collaborative platforms may enable remote optimization and real-time decision support.
Conclusion
Empower 3 CDS custom calculations and reporting provide an objective, efficient, and reproducible approach to chromatographic method development.
Automated scoring minimizes bias, accelerates decision making, and ensures optimal separation conditions are selected based on quantitative metrics.
Reference
- Waters Corporation. Improving Decision Making during Method Development Using Empower 3 CDS Software. Application Brief, 2014.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Improving Effectiveness in Method Development by Using a Systematic Screening Protocol
2014|Waters|Technical notes
Improving Effectiveness in Method Development by Using a Systematic Screening Protocol Margaret Maziarz, Sean M. McCarthy, and Mark Wrona Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E N E F I…
Key words
acquity, acquityuplc, uplcsystematic, systematicprotocol, protocoleffectiveness, effectivenessdevelopment, developmentscreening, screeningimproving, improvingqda, qdamethod, methodusing, usinghss, hsscortecs, cortecscsh, cshscouting
METHOD DEVELOPMENT - The Path to Successful Drug Development Starts with Purposeful Method Development
2014|Waters|Guides
[ APPLICATION NOTEBOOK ] METHOD DEV ELOPMENT The Path to Successful Drug Development Starts with Purposeful Method Development [ INTRODUCTION ] T he Path to Successful Drug Development Starts with Purposeful Method Development The goal of method development in pharmaceutical…
Key words
uplc, uplcacquity, acquitydevelopment, developmentziprasidone, ziprasidonemethod, methodwaters, waterssystematic, systematiccolumn, columnhss, hssclass, classusing, usingparoxetine, paroxetineqcrm, qcrmmetformin, metforminqda
Robust and Rapid Method for Analysis of Active Pharmaceutical Ingredients in Multi-Component Cold and Flu Medication
2019|Waters|Applications
[ APPLICATION NOTE ] Robust and Rapid Method for Analysis of Active Pharmaceutical Ingredients in Multi-Component Cold and Flu Medication Margaret Maziarz and Paul Rainville Waters Corporation, Milford, MA, USA APPLICATION BENEFITS ■■ ■■ Fast and effective development of Pharmaceutical…
Key words
flu, flucold, coldminutes, minutesmedication, medicationingredients, ingredientscaplets, capletsactive, activeacquity, acquityuplc, uplcpharmaceutical, pharmaceuticalmethod, methodcomponent, componentqda, qdarobust, robustdex
APPLICATION NOTEBOOK - IMPURITIES - Developing Safe and Effective Drugs
2016|Waters|Guides
[ APPLICATION NOTEBOOK ] IMPURITIES Developing Safe and Effective Drugs INT RODUCTION NAVIGATION T he pharmaceutical industry is integral in maintaining public health by providing therapeutic and preventative medicines. T he cornerstones of bringing new medicines to market are quality,…
Key words
home, homeuplc, uplcimpurities, impuritiesziprasidone, ziprasidoneusp, uspacquity, acquityimpurity, impuritymethod, methodtioconazole, tioconazoleminutes, minutessimvastatin, simvastatinhplc, hplcusing, usingrelated, relatedanalysis